Skip to Content

Join the 'Oxybutynin' group to help and get support from people like you.

Oxybutynin News

Drug Tied to Dementia Risk Overprescribed to Seniors: Study

Posted 31 Mar 2017 by Drugs.com

THURSDAY, March 30, 2017 – A drug linked to a raised risk of dementia is taken by millions of older Americans who have an overactive bladder, researchers say. More than one-quarter of patients with the urinary problem had been prescribed the drug oxybutynin (Ditropan), an international team of investigators found. Yet, "oxybutynin is a particularly poor drug for overactive bladder in elderly ...

Use of Certain Allergy, Depression Meds Tied to Higher Odds for Dementia

Posted 26 Jan 2015 by Drugs.com

MONDAY, Jan. 26, 2015 – Long-term and/or high-dose use of a class of medications used for hay fever, depression and other ills has been linked in a new study to a higher risk of dementia. The drugs – called anticholinergics – include nonprescription diphenhydramine (Benadryl) and tricyclic antidepressants like doxepin (Sinequan). This class of medications also includes older antihistamines ...

Overactive Bladder a Common Problem, FDA Says

Posted 19 Jan 2015 by Drugs.com

MONDAY, Jan. 19, 2015 – More than 33 million Americans suffer from overactive bladder, including 40 percent of women and 30 percent of men, the U.S. Food and Drug Administration says. There are numerous approved treatments for the condition, but many people don't seek help because they're embarrassed or don't know about therapy options, according to an agency news release. In people with ...

FDA Approves Over-the-Counter Oxytrol for Women to treat Overactive Bladder

Posted 25 Jan 2013 by Drugs.com

January, 25, 2013 – The U.S. Food and Drug Administration today approved Oxytrol for Women, the first over-the-counter treatment for overactive bladder in women ages 18 years and older. Oxytrol will remain available for men with overactive bladder by prescription only. Overactive bladder is a condition in which the bladder squeezes too often or squeezes without warning. Symptoms include ...

Anturol Approved by FDA for the Treatment of Overactive Bladder

Posted 8 Dec 2011 by Drugs.com

PARSIPPANY, N.J. and EWING, N.J., Dec. 8, 2011 /PRNewswire/ – Watson Pharmaceuticals, Inc. and Antares Pharma, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Antares' topical oxybutynin gel 3% product for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and frequency. OAB is a condition that affects more than 33 ...

Ask a Question

Further Information

Related Condition Support Groups

Overactive Bladder, Urinary Incontinence, Hyperhidrosis, Dysuria, Prostatitis, Spina bifida

Related Drug Support Groups

Oxytrol, Ditropan, Gelnique, Urotrol, Ditropan XL, Anturol

Oxybutynin Patient Information at Drugs.com